ENTA ENANTA PHARMACEUTICALS INC
2026Q1 · CUSIP 29251M106 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
131
Δ holders QoQ
0
Breadth percentile
Top 62%
Whale holders
68
Δ whales
-3
Inst. holding value
$338M
New positions
24
Closed positions
24
Price momentum (1Q)
-3.0%
Put / Call
1/2
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2021Q4 | Top 17% | -24.5% | +15.3% |
| 2020Q2 | Top 15% | -8.7% | +6.3% |
| 2018Q2 | Top 19% | -15.7% | +13.2% |
| 2018Q1 | Top 4% | -15.8% | -29.0% |
Options Sentiment
Put holders
1
QoQ: +1
Call holders
2
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.60
EPS YoY
—
Revenue (TTM)
$0.1B
Revenue YoY
+7.4%
Net margin
-89.6%
ROE
-53.2%
Debt ratio
62.9%
FCF (TTM)
-$10M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.